Helpline 07939 046 030
Freephone 0300 102 17 22*

iNForm your Transition to Adult Services

Please note: this new page is a work in progress and is still being updated.

 

Transition is the process of moving your care from children’s to adult's services. It is an extremely important process as growing up means you will take control of your healthcare needs.

Transition refers to the full process, including the initial planning, the actual transfer between children's and adult's services, and the support you should receive throughout the whole process.

We considered providing a comprehensive guide to transition a few years back, but after careful consideration and after talking with various hospital units across the country, we felt that this would not be very practical or very helpful, as every regional paediatric department has their own internal guidelines and practices. If we insisted on a UK-wide approach, it would not necessarily be helpful as it may cause tensions. Since you need to work closely with your own care providers, you need everything to be friendly, and to work together with your local hospital in a positive way.

We therefore feel it will be more useful for us to educate you, your families, and your carers, on what basic level of support you should expect to receive, as well as how our team of Nerve Tumours UK Specialist NF Nurses and Advisors can support you and your family throughout your transition journey.

Obviously, we have taken into consideration the guidelines set out by NICE, the National Institute for Health and Care Excellence, for transitionYou can read them by clicking the button below.

Learning to manage your NF

What to expect

Not all people are the same. Some of us are good at reading, while others are good at sport. After all, the world would be a very boring place if we were all the same!

Therefore, your transition journey should be suited to you and your needs, and your healthcare provider must make sure that the support you receive meets these needs.

Considerations

You and your nurse need to discuss how best you will manage your condition, and so they need to discuss:

  • your maturity, as the age at which you transition to adult services can vary
  • your cognitive and learning abilities
  • if you need mental health support
  • any problems you experience with your NF
  • your family and personal circumstances
  • who looks after you
  • how you prefer to communicate

Planning ahead

Your healthcare team should start planning for your transition to adult medical services from school year 9 (when you are aged 13 or 14) at the latest. For any young people with education, health and care plans, this must happen from school year 9.

Any support must be the right support for you, so we need to make sure that:

  • it's based on your abilities and strengths
  • the plan is a useful and workable one
  • it is not a 'pre‑determined' set plan, because everyone is different!
  • it clearly shows and identifies the type of help and support that can and should be provided for you, which also includes the support that Nerve Tumours UK can offer to you and your family or carers

Our support is wide-reaching and gives you access to our team of regional nurses, the National Helpline, online support groups and all of our downloadable literature.

If there is any information you need that is not on hand, contact us and we will find out for you.

Parents and carers

Although it is better for young people to take charge of their own healthcare requirements as they grow up and become more confident, we do realise how daunting this can be for many.

So we will always welcome your parents and carers to be part of this process, but we will only ever talk to them if that is what you want. It is really important that you tell your healthcare providers if you would like others involved in your planning chats.

Safeguarding

We have to make sure you and all young people are safe. All healthcare workers involved in supporting you through transition are responsible for sharing safeguarding information with other organisations in line with local information sharing and confidentiality policies.

We are able to provide a copy of our policy if this would be helpful.

Your voice

Young people are the most important voice in this transition journey, so the Specialist NF Nurses and Advisors, who are all qualified medical professionals, will:

  • treat all of you with respect and as an equal partner in the process
  • listen to you and take a full account of your views and needs
  • involve you and your family or carers
  • liaise with your GP (if needed)
  • support you to make decisions and build your confidence so you can manage your own care in the years to come
  • fully involve you in all decision making and plans

Topics you should talk about

Here is a list of some of the topics that your care team should talk to you about and the topics that should be looked into during the transition process.

The Specialist NF Nurses and Advisors will cover all important topics, such as:

  • a full explanation of your ongoing medical needs
  • your emotional requirements
  • relationships
  • contraception and family planning
  • education and/or employment, as well as how we can further help in these areas
  • the benefits system

Your condition

Some of you will currently be looked after by the Complex Teams based in St Mary's Hospital in Manchester and Guy's and St Thomas' Hospital in London, by the NF2 service, or by local paediatric units, while others may be under the care of the Nerve Tumours UK Team of Specialist NF Nurses.

Your current healthcare professional will liaise with the teams in adult's services to ensure a smooth transition depending on your needs.

Complex NF1

[Information to follow].

Non-complex NF1

Your local paediatrics units, or our team of Specialist NF Nurses, will liaise directly with your GP to ensure they are fully briefed about your condition and your medical history. They will advise the level of care that you require going forwards.

On some occasions it may be necessary to prolong your stay under paediatric services, but this is nothing to worry about as it happens often and will be managed locally.

You may find this guide easy to use when explaining your condition to others.

NF2

Not all NF2 services operate in the same way, and the following is currently under review across them, but this is a sample letter of what you might expect to receive when you reach transition age.

...and topics you will need to think about and discuss at various ages.

Managing your healthcare

To manage your healthcare effectively, you need to be aware of what help is out there.

Here are some more useful contacts and resources, particularly for teenagers, compiled by Dr. Shruti Garg, Clinical Senior Lecturer in Translational Child Psychiatry at the University of Manchester, Honorary Consultant Child and Adolescent Psychiatrist at the Royal Manchester Children’s Hospital, and Member of the Nerve Tumours UK Medical Advisory Board.

Nerve Tumours UK

Whenever you need us, we will be there to support you.

Always remember that we will take any question that you have seriously. No question is ever too small or too daft!

We want to equip you with the ability and tools to build confidence and independence, so you can take charge of your healthcare.

Information leaflets

As well as our regional Specialist Nurses and Advisors, we offer a host of downloadable leaflets for you to look at, and you can always talk to Specialist NF Nurses on our helpline.

Nerve Tumours UK Helpline

Remember: if you have questions, you can call the Nerve Tumours UK Helpline at any time during the transition process. No question is ever too silly!

NTUK Helpline

Nerve Tumours UK Specialist NF Nurse and Advisor-led clinics

These clinics are available in some regions to help with ease of transition. Ask if these are available in your area, or book an online meeting with the Nerve Tumours UK Helpline team.

Easy to understand

Our Specialist NF Nurses and Advisors agree to always speak in a clear simple manner, while all downloadable leaflets are written in a clear, easy to read, concise format. But please remember: we are here to help, so feel free to ask us any questions you need answers to!

Thinking of going to university or college?

You might find the information in our university guide useful.

iNForm your university

Find out more

Useful links

Helpful charities

We are linked to many other helpful charities that will help you make your way through the education, employment and benefits systems.

Find out more

Community support groups

We also run closed community support groups for you to talk to each other.

Find out more

Masterclasses in NF: Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Prof. Dr. Berthold Pemp

OT Sabine Koinig

Masterclasses in NF: Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Assoc. Prof. Dr. Gregor Kasprian

Dr. Hector Salvador, MD

Masterclasses in NF: The Patients’ Perspective: A Masterclass on NF Care Held by NF Patients

Masterclasses in NF: Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

 

Michel Kalamarides MD

Masterclasses in NF: Management Of Plexiform Neurofibromatosis in NF1- Rianne Oosterbrink, Justus L Groen, Karine Lascelles

Masterclasses in NF1: 1.Management Of Plexiform Neurofibromatosis in NF1

Rianne Oosterbrink MD

Justus L Groen MD

Karine Lascelles MD

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK